In June 2026, 2 Canadian cities will host several FIFA World Cup soccer matches. Health care systems may have to play host too, as large numbers of visitors to these cities will increase pressure on ...
Key points A 75-year-old woman presented to the emergency department with acute confusion and lethargy on the third day of her first cycle of definitive radical chemoradiation for squamous cell ...
The prevalence rises with age, reaching 5% to 7% among patients older than 70 years.[1][1] The differential diagnosis of an adrenal mass includes adenomas (both functional and nonfunctional), ...
Canada revised its medical assistance in dying (MAiD) legislation to extend eligibility to individuals without a reasonably ...
A 26-year-old woman presented to a dermatologist’s office for psoriasis, reporting discomfort due to itching and scaling. During the consultation, we incidentally noticed a smooth, yellow–white, ...
Croup develops in more than 80 000 Canadian children each year, making it the second most common cause of respiratory distress in the first decade of life. [1] [1], [2] [2] It affects boys more than ...
BACKGROUND: The Global Burden of Disease Study represents a large and systematic effort to describe the burden of diseases and injuries over the past 3 decades. We aimed to summarize the Canadian data ...
An 83-year-old man presented to the emergency department with fatigue and proximal upper- and lower-limb weakness, 10 days after a diarrheal illness. His medical history included type 2 diabetes ...
Eustachian tube dysfunction leads to inadequate ventilation of the middle ear It is caused by inflammation or narrowing of the eustachian tube, which leads to aural fullness and muffled hearing ...
Global prevalence is approximately 1–7 per 100 000 individuals, with women slightly more frequently affected than men. Peak occurrences are at age 16–25 and 36–46 years. A minority of cases occur in ...
Semaglutide, liraglutide, lixisenatide, dulaglutide, and tirzepatide are the current GLP1RAs available in Canada. These are approved for the treatment of type 2 diabetes and obesity and have been used ...
Clinicians may be concerned about the potential of electronic patient portals to disrupt the therapeutic relationship, deliver medicolegal burdens or harm patients, but these fears are largely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback